Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Francia
  4. Euronext Paris
  5. Cellectis S.A.
  6. Notizie
  7. Altre lingue
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Rapporto
Tempo reale Euronext Paris  -  17:35 29/11/2022
2.204 EUR   -5.16%
16/11Le azioni europee sono piatte negli scambi incerti di mercoledì, mentre pesano le tensioni geopolitiche
MT
10/11Gli ADR europei aumentano, mentre i mercati globali reagiscono ai dati sull'inflazione degli USA
MT
09/11Gli ADR europei si muovono al ribasso nelle contrattazioni di mercoledì
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivatiFondi 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Giorni
:
Ore
:
Minuti
:
Secondi
Notizie in altre lingue su CELLECTIS S.A.
24/11Cellectis S A: Document AMF CP. 2022E873261
21/11Cellectis S A: Document AMF CP. 2022E872622
18/11Cellectis S A: Document AMF CP. 2022E872470
16/11European Equities Flat in Choppy Trade Wednesday as Geopolitical Tensions Weigh
11/11Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling ..
11/11Cellectis Presents Pre-Clinical Data on TALEN-edited Smart CAR T-cells Overcoming Key C..
11/11Séance de gala à Wall Street
11/11En direct des marchés : Teleperformance, Airbus, Richemont, Cellne..
10/11European ADRs Surge Higher as Global Markets React to US Inflation Data
10/11Cellectis : présente des données précliniques sur TALEN
10/11Cellectis présente des données précliniques sur des cellules « smart » CAR T éditées pa..
10/11Cellectis Presents Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Overcoming Key ..
10/11Cellectis Presents Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Overcoming Key ..
10/11Cellectis publie un article dans Frontiers Bioengineering and Biotechnology sur une str..
10/11Cellectis publie un article dans Frontiers Bioengineering and Biotechnology sur une str..
10/11Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling ..
09/11European ADRs Move Lower in Wednesday Trading
08/11European ADRs Move Higher in Tuesday Trading, Adding to Monday's Gains
04/11Transcript : Cellectis S.A., Q3 2022 Earnings Call, Nov 04, 2022
04/11Bolsa de Madrid: Y China emerge...
04/11Et la Chine surgit…
04/11En Direct des Marchés : Société Générale, Kering, Teleperformance,..
03/11Cellectis S A: COMPTES CONSOLIDES COMPTES INTERMEDIAIRES AU 30 septembre 2022
03/11Cellectis S A: PRELIMINARY NOTE - Form 6-K
03/11Cellectis S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
03/11Cellectis publie ses résultats financiers pour le troisième trimestre et pour les neuf ..
03/11Cellectis publie ses résultats financiers pour le troisième trimestre et pour les neuf ..
03/11Cellectis Provides Business Update and Reports Financial Results for Third Quarter and ..
03/11Cellectis Provides Business Update and Reports Financial Results for Third Quarter and ..
03/11Cellectis présentera des données cliniques sur AMELI-01 et des données précliniques sur..
03/11Cellectis to Showcase Clinical Data from AMELI-01 and Preclinical Data from UCARTCS1 at..
03/11Cellectis présentera des données cliniques sur AMELI-01 et des données précliniques sur..
03/11Cellectis to Showcase Clinical Data from AMELI-01 and Preclinical Data from UCARTCS1 at..
03/11Cellectis to Showcase Clinical Data from Ameli-01 and Preclinical Data from Ucartcs1 At..
31/10European ADRs Move Lower in Monday Trading
27/10Cellectis organise une conférence téléphonique pour présenter ses résultats financiers ..
27/10Cellectis to Report Third Quarter 2022 Financial Results
27/10Cellectis to Report Third Quarter 2022 Financial Results
26/10European ADRs Move Higher in Wednesday Trading
21/10European ADRs Move Higher in Friday Trading
12/10Cellectis Presents Data on Two TALEN-based Gene Therapy Preclinical Programs for Patien..
12/10Cellectis : présente ses données basées sur TALEN
12/10Bolsa de Madrid: El peso de las palabras
12/10Le poids des mots
12/10EN DIRECT DES MARCHES : LVMH, Eutelsat, Stellantis, BNP Paribas, V..
11/10Cellectis présente des données sur deux programmes précliniques de thérapies géniques b..
11/10Cellectis présente des données sur deux programmes précliniques de thérapies géniques b..
11/10Cellectis Presents Data on Two TALEN®-based Gene Therapy Preclinical Programs for Patie..
11/10Cellectis Presents Data on Two TALEN®-based Gene Therapy Preclinical Programs for Patie..
11/10Cellectis Presents Data on Two TALEN®-based Gene Therapy Preclinical Programs for Patie..
11/10Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infil..
10/10European ADRs Move Lower in Monday Trading
07/10European ADRs Move Lower in Friday Trading
06/10Cellectis : présentera des données contre le cancer
06/10Bolsa de Madrid: El mercado recupera parte de su libido
06/10Le marché retrouve un peu de sa libido
06/10EN DIRECT DES MARCHES : Engie, STMicro, EDF, Nexans, Aramis, GE, T..
05/10Cellectis présentera des données précliniques sur des cellules “smart” CAR ..
05/10Cellectis to Present Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Supporting Im..
05/10Cellectis to Present Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Supporting Im..
05/10European ADRs Move Sharply Lower in Wednesday Trading
03/10Calyxt, Inc.: Entry into a Material Definitive Agreement, Other Events, Financial Stateme..
29/09European ADRs Move Lower in Thursday Trading
29/09Ça s'emballe derrière la Banque d'Angleterre
29/09EN DIRECT DES MARCHES : Sanofi, Renault, Accor, Worldline, Valneva..
29/09Biopharmaceutical Group Cellectis Hires Chief Medical Officer
28/09Cellectis Promotes Mark Frattini to Chief Medical Officer
28/09Cellectis Appoints Mark Frattini, M.D., Ph.D. as Chief Medical Officer
28/09Cellectis Appoints Mark Frattini as Chief Medical Officer
28/09Cellectis nomme Mark Frattini, M.D., Ph.D., en tant que directeur médical
27/09Cellectis S A: Document AMF CP. 2022E863159
23/09European ADRs Fall in Friday Trading
23/09Allogene Stocks Fall as Servier Abandons Anti-CD19 Partnership
22/09Cellectis S.A. and Les Laboratoires Servier Sas and Institut De Recherches Internationa..
22/09Calyxt, Inc.: Other Events, Financial Statements and Exhibits (form 8-K)
21/09European ADRs Move Lower in Wednesday Trading
20/09European ADRs Move Lower in Tuesday Trading
19/09Zentalis Pharmaceuticals Hires Carrie Brownstein as Chief Medical Officer
08/09European ADRs Move Slightly Higher in Thursday Trading
07/09European ADRs Move Lower in Wednesday Trading
07/09Transcript : Cellectis S.A. Presents at Citi's 17th Annual BioPharma Conferen..
06/09European ADRs Move Higher in Tuesday Trading
05/09Cellectis S A: Corporate Presentation - September 2022
02/09European ADRs Climb Sharply Higher in Friday Trading
01/09Cellectis annonce sa participation à quatre conférences investisseurs en septembre
01/09Cellectis annonce sa participation à quatre conférences investisseurs en septembre
01/09Cellectis Announces Participation in Four Upcoming Investor Conferences in September
01/09Cellectis S A: Document AMF CP. 2022E858948
31/08European ADRs Fall in Wednesday Trading
26/08European ADRs Move Lower in Friday Trading
25/08Cellectis S A: Document AMF CP. 2022E858188
24/08European ADRs Move Lower in Wednesday Trading
22/08European ADRs Move Lower in Monday Trading
19/08European ADRs Move Lower in Friday Trading
18/08European ADRs Move Lower in Thursday Trading
17/08European ADRs Move Lower in Wednesday Trading
16/08Cellectis S A: Document AMF CP. 2022E857305
15/08European ADRs Move Sharply Lower in Monday Trading
12/08European ADRs Move Slightly Lower in Friday Trading
11/08European ADRs Move Lower in Thursday Trading